STEANN PHARMA: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
STEANN PHARMA
Largest movements
- Tangible fixed assets +€389,204
up €389,204 (+659.3%), from €59,036 to €448,239
of which Land and buildings: +€398,773
- Receivables within one year +€22,373
up €22,373 (+5212.9%), from €429 to €22,802
of which Other amounts receivable: +€21,969
- Other debts +€419,063
up €419,063 (+150.4%), from €278,618 to €697,681
- Debts after one year -€57,725
down €57,725 (-14.8%), from €389,494 to €331,769
- Reserves +€46,556
up €46,556 (+7.1%), from €655,470 to €702,026
- Accrued charges and deferred income +€24,299
up €24,299 (+97.3%), from €24,967 to €49,266
- Depreciation +€57,384
up €57,384 (+1254.3%), from €4,575 to €61,959
- Taxes -€33,052
down €33,052 (-58.6%), from €56,427 to €23,375
- Gross operating margin -€26,184
down €26,184 (-12.8%), from €204,397 to €178,213
- Financial charges +€21,966
up €21,966 (+97.2%), from €22,598 to €44,564
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €1,492,721 | €1,921,720 | +€428,999 | +28.7% |
| Fixed assets | 21/28 | €1,476,403 | €1,865,606 | +€389,204 | +26.4% |
| Tangible fixed assets | 22/27 | €59,036 | €448,239 | +€389,204 | +659.3% |
| Land and buildings | 22 | - | €398,773 | +€398,773 | |
| Plant, machinery and equipment | 23 | - | €2,653 | +€2,653 | |
| Furniture and vehicles | 24 | €56,536 | €44,314 | -€12,222 | -21.6% |
| Other tangible fixed assets | 26 | €2,500 | €2,500 | = | 0.0% |
| Financial fixed assets | 28 | €1,417,367 | €1,417,367 | = | 0.0% |
| Current assets | 29/58 | €16,319 | €56,114 | +€39,795 | +243.9% |
| Amounts receivable within one year | 40/41 | €429 | €22,802 | +€22,373 | +5212.9% |
| Trade receivables | 40 | - | €404 | +€404 | |
| Other amounts receivable | 41 | €429 | €22,398 | +€21,969 | +5118.8% |
| Cash at bank and in hand | 54/58 | €13,647 | €29,209 | +€15,562 | +114.0% |
| Deferred charges and accrued income | 490/1 | €2,243 | €4,102 | +€1,860 | +82.9% |
| Total equity and liabilities | 10/49 | €1,492,721 | €1,921,720 | +€428,999 | +28.7% |
| Equity | 10/15 | €730,470 | €777,026 | +€46,556 | +6.4% |
| Contributions | 10/11 | €75,000 | €75,000 | = | 0.0% |
| Reserves | 13 | €655,470 | €702,026 | +€46,556 | +7.1% |
| Distributable reserves | 133 | €655,470 | €702,026 | +€46,556 | +7.1% |
| Amounts payable | 17/49 | €762,251 | €1,144,693 | +€382,442 | +50.2% |
| Amounts payable after more than one year | 17 | €389,494 | €331,769 | -€57,725 | -14.8% |
| Financial debts | 170/4 | €389,494 | €331,769 | -€57,725 | -14.8% |
| Amounts payable within one year | 42/48 | €347,789 | €763,658 | +€415,869 | +119.6% |
| Current portion of amounts payable after more than one year | 42 | €56,953 | €57,725 | +€772 | +1.4% |
| Trade debts | 44 | €1,718 | €884 | -€834 | -48.5% |
| Suppliers | 440/4 | €1,718 | €884 | -€834 | -48.5% |
| Taxes, remuneration and social security | 45 | €10,501 | €7,368 | -€3,133 | -29.8% |
| Taxes | 450/3 | €8,724 | €6,888 | -€1,836 | -21.0% |
| Remuneration and social security | 454/9 | €1,777 | €480 | -€1,297 | -73.0% |
| Other amounts payable | 47/48 | €278,618 | €697,681 | +€419,063 | +150.4% |
| Accrued charges and deferred income | 492/3 | €24,967 | €49,266 | +€24,299 | +97.3% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €4,575 | €61,959 | +€57,384 | +1254.3% |
| Other operating charges | 640/8 | €1,505 | €1,758 | +€253 | +16.8% |
| Gross operating margin | 9900 | €204,397 | €178,213 | -€26,184 | -12.8% |
| Operating profit (loss) | 9901 | €198,317 | €114,496 | -€83,821 | -42.3% |
| Financial charges | 65/66B | €22,598 | €44,564 | +€21,966 | +97.2% |
| Recurring financial charges | 65 | €22,598 | €44,564 | +€21,966 | +97.2% |
| Profit (loss) for the period before taxes | 9903 | €175,718 | €69,932 | -€105,787 | -60.2% |
| Income taxes | 67/77 | €56,427 | €23,375 | -€33,052 | -58.6% |
| Profit (loss) for the period | 9904 | €119,291 | €46,556 | -€72,735 | -61.0% |
| Profit (loss) for the period to be appropriated | 9905 | €119,291 | €46,556 | -€72,735 | -61.0% |
Source: filed annual accounts (NBB), fiscal years ended 31 March 2024 and 31 March 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 7 October 2026 via checked.be.